Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer.
about
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast CancerReview of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrantSignificant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000.Clinical utility of exemestane in the treatment of breast cancerWhat do we know about the mechanisms of aromatase inhibitor resistance?Understanding the mechanisms of aromatase inhibitor resistance.Efficacy of exemestane in korean patients with metastatic breast cancer after failure of nonsteroidal aromatase inhibitorsAromatase inhibitors in post-menopausal metastatic breast carcinoma.Anastrozole for malignant and benign conditions: present applications and future therapeutic integrations.Progression of endocrine therapies for breast cancer: where are we headed?Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.Endocrine therapy for the treatment of postmenopausal women with breast cancer.Cotargeting of CYP-19 (aromatase) and emerging, pivotal signalling pathways in metastatic breast cancer.Long-term complete remission of metastatic breast cancer, induced by a steroidal aromatase inhibitor after failure of a non-steroidal aromatase inhibitor.Exemestane in postmenopausal women with early or advanced breast cancer: a review.Management of patients with metastatic breast cancer.mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions.Treatment of metastatic breast cancer in women aged 65 years and older.Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer.Where does radioimmunotherapy fit in the management of breast cancer?Advances in mechanisms of resistance to aromatase inhibitors.Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.Everolimus and its role in hormone-resistant and trastuzumab-resistant metastatic breast cancer.Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.Aromatase, aromatase inhibitors, and breast cancer
P2860
Q26785496-E485F542-8953-4142-979D-11FE7A485740Q28076777-6B726903-43AE-49F4-8104-3720393A02D9Q33858930-855C5B25-02DC-4EB6-89E1-BDA91A41B882Q35683807-2F1C72EE-6236-4941-9B0B-3DDFC23A4087Q35691554-3E38E4A2-DE35-45AF-848B-A81E8817AFE6Q36393053-008E57E5-41F8-4374-8160-565B6CE0FB85Q36764008-D7658EB6-5A8B-4652-8DEA-B8B395A39B95Q36861597-B5FDE8FB-BCF2-4EE3-A924-CEC519188CB4Q36967279-42D4949B-9083-4465-A33E-6042C603E818Q37004695-73080EFB-9B52-4394-A062-17FDAA450C0BQ37366511-D8D663D7-54CC-4093-8814-95B4F01E6063Q37385376-9FE0E4C6-D041-4A6D-BD3C-D632A3B174E7Q37570653-972D53DB-A7A8-4A7A-9976-4D5F60648E6AQ37607281-0866D131-47F7-4063-946E-AE92E5F926D7Q37766896-A0335648-8791-4610-8089-4FC86D3B677EQ37933166-5733751F-362B-40A1-AFFE-94D82EEFCE2AQ38007148-EDCB5FE0-F2F4-4B1D-B597-C4D39169B6A7Q38023511-5E5FCB9A-5D2B-401F-BADE-38DB860F2DAFQ38044021-4DD41639-CCF1-4A66-A4C2-A920CD4DC74FQ38125535-D10DFC16-97A9-4BFF-91A5-BC28FB38A795Q38190106-7D39BA52-BDEE-4508-8851-3945319F1B91Q39185424-34D4C30B-C4EB-46A8-98A3-63B2948CF26AQ39520887-8CD60915-C418-4E98-B05A-17DDBA49DD7CQ46855418-B97C138F-DCD4-4C46-A019-8071667C9542Q57137315-848EAF9E-99AC-4550-AAB1-B920B264D3EB
P2860
Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Sequential treatment with exem ...... ors in advanced breast cancer.
@en
Sequential treatment with exem ...... ors in advanced breast cancer.
@nl
type
label
Sequential treatment with exem ...... ors in advanced breast cancer.
@en
Sequential treatment with exem ...... ors in advanced breast cancer.
@nl
prefLabel
Sequential treatment with exem ...... ors in advanced breast cancer.
@en
Sequential treatment with exem ...... ors in advanced breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Sequential treatment with exem ...... ors in advanced breast cancer.
@en
P2093
Federico Castiglione
Fiorella Pepi
Gianfilippo Bertelli
Laura Bertolotti
Marcella Occelli
Marco Merlano
Ornella Fusco
Ornella Garrone
Robert C F Leonard
P2860
P304
P356
10.1159/000090985
P577
2005-01-01T00:00:00Z